Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	allyl-alcohol dehydrogenase activity	AKR1B10 AKR1B1	5.31e-05	4	60	2	GO:0047655
GeneOntologyMolecularFunction	dATP binding	ST13P5 ST13	8.83e-05	5	60	2	GO:0032564
GeneOntologyMolecularFunction	adenyl deoxyribonucleotide binding	ST13P5 ST13	1.32e-04	6	60	2	GO:0032558
GeneOntologyMolecularFunction	purine deoxyribonucleotide binding	ST13P5 ST13	1.85e-04	7	60	2	GO:0032554
GeneOntologyMolecularFunction	deoxyribonucleotide binding	ST13P5 ST13	3.15e-04	9	60	2	GO:0032552
GeneOntologyMolecularFunction	cytoskeletal protein binding	MYH1 KIFBP CENPF PPP1R9A SYNE2 CGN MYO18A TMOD1 DMD CCDC181 TNNT1	3.81e-04	1099	60	11	GO:0008092
GeneOntologyMolecularFunction	actin binding	MYH1 PPP1R9A SYNE2 CGN MYO18A TMOD1 DMD	5.63e-04	479	60	7	GO:0003779
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	CECR2 MYO18A CHD2 RAD50	5.78e-04	127	60	4	GO:0008094
GeneOntologyMolecularFunction	G-quadruplex DNA binding	XRN1 RAD50	7.89e-04	14	60	2	GO:0051880
GeneOntologyMolecularFunction	retinal dehydrogenase activity	AKR1B10 AKR1B1	7.89e-04	14	60	2	GO:0001758
GeneOntologyMolecularFunction	aldose reductase (NADPH) activity	AKR1B10 AKR1B1	7.89e-04	14	60	2	GO:0004032
GeneOntologyMolecularFunction	Hsp70 protein binding	ST13P5 ST13 IQCG	9.01e-04	63	60	3	GO:0030544
GeneOntologyMolecularFunction	tropomyosin binding	TMOD1 TNNT1	9.09e-04	15	60	2	GO:0005523
GeneOntologyMolecularFunction	all-trans-retinol dehydrogenase (NADP+) activity	AKR1B10 AKR1B1	9.09e-04	15	60	2	GO:0052650
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	CECR2 MYO18A CHD2 NIPBL RAD50	1.14e-03	262	60	5	GO:0140097
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	SEPTIN8 SEPTIN3 SEPTIN14 MYO18A CCT6B CHD2 DYNC1H1 RAD50	2.13e-03	775	60	8	GO:0017111
GeneOntologyMolecularFunction	ATP-dependent activity	MYH1 CECR2 MYO18A CCT6B CHD2 DYNC1H1 RAD50	2.36e-03	614	60	7	GO:0140657
GeneOntologyMolecularFunction	alcohol dehydrogenase (NADP+) activity	AKR1B10 AKR1B1	2.97e-03	27	60	2	GO:0008106
GeneOntologyMolecularFunction	dynein complex binding	CFAP100 CENPF	3.19e-03	28	60	2	GO:0070840
GeneOntologyMolecularFunction	dynein light intermediate chain binding	RILPL1 DYNC1H1	3.19e-03	28	60	2	GO:0051959
GeneOntologyMolecularFunction	pyrophosphatase activity	SEPTIN8 SEPTIN3 SEPTIN14 MYO18A CCT6B CHD2 DYNC1H1 RAD50	3.47e-03	839	60	8	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	SEPTIN8 SEPTIN3 SEPTIN14 MYO18A CCT6B CHD2 DYNC1H1 RAD50	3.50e-03	840	60	8	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	SEPTIN8 SEPTIN3 SEPTIN14 MYO18A CCT6B CHD2 DYNC1H1 RAD50	3.50e-03	840	60	8	GO:0016818
GeneOntologyMolecularFunction	aldo-keto reductase (NADPH) activity	AKR1B10 AKR1B1	4.16e-03	32	60	2	GO:0004033
GeneOntologyMolecularFunction	protein domain specific binding	USP8 CTR9 PPP1R9A ZBTB21 DMD ST13P5 NIPBL ST13	4.48e-03	875	60	8	GO:0019904
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH1 MYO18A DYNC1H1	5.39e-03	118	60	3	GO:0003774
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	CECR2 CHD2	5.53e-03	37	60	2	GO:0140658
GeneOntologyMolecularFunction	RNA polymerase II complex binding	RTF1 CTR9	6.13e-03	39	60	2	GO:0000993
GeneOntologyMolecularFunction	unfolded protein binding	CCT6B ST13P5 ST13	6.46e-03	126	60	3	GO:0051082
GeneOntologyBiologicalProcess	cytoskeleton-dependent cytokinesis	SEPTIN8 USP8 SEPTIN3 CECR2 SEPTIN14 CHMP3	1.67e-06	127	59	6	GO:0061640
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	CFAP100 CCDC13 KIFBP SYNE2 CGN CHMP3 MAP7D2 CEP126 DYNC1H1 CCDC40 IQCG	5.28e-06	720	59	11	GO:0000226
GeneOntologyBiologicalProcess	organelle assembly	CFAP100 CCDC13 CENPF SYNE2 CHMP3 TMOD1 RILPL1 CEP126 RB1CC1 TNNT1 DYNC1H1 CCDC40 IQCG	1.54e-05	1138	59	13	GO:0070925
GeneOntologyBiologicalProcess	cytokinesis	SEPTIN8 USP8 SEPTIN3 CECR2 SEPTIN14 CHMP3	2.53e-05	204	59	6	GO:0000910
GeneOntologyBiologicalProcess	negative regulation of protein refolding	ST13P5 ST13	8.00e-05	5	59	2	GO:0061084
GeneOntologyBiologicalProcess	regulation of protein refolding	ST13P5 ST13	1.20e-04	6	59	2	GO:0061083
GeneOntologyBiologicalProcess	cell division	SEPTIN8 USP8 SEPTIN3 CENPF CECR2 SEPTIN14 SYCP1 CHMP3 DYNC1H1	1.51e-04	697	59	9	GO:0051301
GeneOntologyBiologicalProcess	negative regulation of protein folding	ST13P5 ST13	1.67e-04	7	59	2	GO:1903333
GeneOntologyBiologicalProcess	cell cycle process	SEPTIN8 USP8 SEPTIN3 CENPF CECR2 SEPTIN14 SYCP1 CHMP3 CEP126 NIPBL DYNC1H1 KCNH5 RAD50	1.75e-04	1441	59	13	GO:0022402
GeneOntologyBiologicalProcess	microtubule-based process	CFAP100 CCDC13 KIFBP SYNE2 CGN CHMP3 MAP7D2 CEP126 DYNC1H1 CCDC40 IQCG	1.78e-04	1058	59	11	GO:0007017
GeneOntologyBiologicalProcess	cilium assembly	CFAP100 CCDC13 SYNE2 RILPL1 CEP126 CCDC40 IQCG	2.65e-04	444	59	7	GO:0060271
GeneOntologyBiologicalProcess	nucleus localization	SYNE2 DMD DYNC1H1	2.71e-04	44	59	3	GO:0051647
GeneOntologyBiologicalProcess	daunorubicin metabolic process	AKR1B10 AKR1B1	2.86e-04	9	59	2	GO:0044597
GeneOntologyBiologicalProcess	doxorubicin metabolic process	AKR1B10 AKR1B1	3.57e-04	10	59	2	GO:0044598
GeneOntologyBiologicalProcess	polyketide metabolic process	AKR1B10 AKR1B1	3.57e-04	10	59	2	GO:0030638
GeneOntologyBiologicalProcess	aminoglycoside antibiotic metabolic process	AKR1B10 AKR1B1	3.57e-04	10	59	2	GO:0030647
GeneOntologyBiologicalProcess	cilium organization	CFAP100 CCDC13 SYNE2 RILPL1 CEP126 CCDC40 IQCG	4.04e-04	476	59	7	GO:0044782
GeneOntologyCellularComponent	septin complex	SEPTIN8 SEPTIN3 SEPTIN14	8.00e-06	14	60	3	GO:0031105
GeneOntologyCellularComponent	septin ring	SEPTIN8 SEPTIN3 SEPTIN14	8.00e-06	14	60	3	GO:0005940
GeneOntologyCellularComponent	cell cortex	SEPTIN8 SEPTIN3 SEPTIN14 PPP1R9A TMOD1 RAI14 DYNC1H1 SPINK5	1.04e-05	371	60	8	GO:0005938
GeneOntologyCellularComponent	septin cytoskeleton	SEPTIN8 SEPTIN3 SEPTIN14	1.23e-05	16	60	3	GO:0032156
GeneOntologyCellularComponent	manchette	CCDC181 DYNC1H1 IQCG	7.00e-05	28	60	3	GO:0002177
GeneOntologyCellularComponent	Cdc73/Paf1 complex	RTF1 CTR9	1.69e-04	7	60	2	GO:0016593
GeneOntologyCellularComponent	actin cytoskeleton	MYH1 PPP1R9A CGN MYO18A TMOD1 RAI14 TNNT1 IQCG	2.29e-04	576	60	8	GO:0015629
GeneOntologyCellularComponent	condensed chromosome	CENPF KMT5B RASSF2 SYCP1 CHMP3 RAD50	2.46e-04	307	60	6	GO:0000793
GeneOntologyCellularComponent	filopodium	PPP1R9A SYNE2 DMD DYNC1H1	4.31e-04	123	60	4	GO:0030175
GeneOntologyCellularComponent	myosin complex	MYH1 CGN MYO18A	6.52e-04	59	60	3	GO:0016459
GeneOntologyCellularComponent	sarcomere	MYH1 SYNE2 TMOD1 DMD TNNT1	7.38e-04	249	60	5	GO:0030017
GeneOntologyCellularComponent	myofibril	MYH1 SYNE2 TMOD1 DMD TNNT1	1.11e-03	273	60	5	GO:0030016
GeneOntologyCellularComponent	chromosome, centromeric region	CENPF KMT5B RASSF2 SYCP1 CHMP3	1.17e-03	276	60	5	GO:0000775
GeneOntologyCellularComponent	actin-based cell projection	PPP1R9A SYNE2 DMD AKR1B1 DYNC1H1	1.21e-03	278	60	5	GO:0098858
GeneOntologyCellularComponent	chromosomal region	CENPF KMT5B RASSF2 SYCP1 CHMP3 RAD50	1.29e-03	421	60	6	GO:0098687
GeneOntologyCellularComponent	contractile muscle fiber	MYH1 SYNE2 TMOD1 DMD TNNT1	1.45e-03	290	60	5	GO:0043292
GeneOntologyCellularComponent	cell division site	SEPTIN8 SEPTIN3 SEPTIN14	1.58e-03	80	60	3	GO:0032153
GeneOntologyCellularComponent	filopodium membrane	SYNE2 DMD	1.64e-03	21	60	2	GO:0031527
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	CFAP100 CENPF AKR1B1 DYNC1H1 CCDC40	2.15e-03	317	60	5	GO:0032838
GeneOntologyCellularComponent	condensed chromosome, centromeric region	CENPF KMT5B RASSF2 CHMP3	2.29e-03	193	60	4	GO:0000779
GeneOntologyCellularComponent	myosin filament	MYH1 MYO18A	2.33e-03	25	60	2	GO:0032982
GeneOntologyCellularComponent	striated muscle thin filament	TMOD1 TNNT1	2.72e-03	27	60	2	GO:0005865
GeneOntologyCellularComponent	myosin II complex	MYH1 MYO18A	2.92e-03	28	60	2	GO:0016460
GeneOntologyCellularComponent	pronucleus	CENPF RAD50	2.92e-03	28	60	2	GO:0045120
GeneOntologyCellularComponent	cytoplasmic region	CFAP100 CENPF AKR1B1 DYNC1H1 CCDC40	3.71e-03	360	60	5	GO:0099568
GeneOntologyCellularComponent	midbody	USP8 CENPF CHMP3 CEP126	3.79e-03	222	60	4	GO:0030496
GeneOntologyCellularComponent	myofilament	TMOD1 TNNT1	3.80e-03	32	60	2	GO:0036379
GeneOntologyCellularComponent	lamellipodium	PPP1R9A SYNE2 DMD SNX2	4.30e-03	230	60	4	GO:0030027
GeneOntologyCellularComponent	microtubule organizing center	CFAP100 CCDC13 CENPF ITSN2 MYO18A RILPL1 CEP126 DYNC1H1	4.57e-03	919	60	8	GO:0005815
GeneOntologyCellularComponent	nuclear envelope	UBXN4 CENPF SYNE2 CHMP3 RB1CC1 DYNC1H1	5.29e-03	560	60	6	GO:0005635
Domain	Septin	SEPTIN8 SEPTIN3 SEPTIN14	8.37e-06	13	59	3	PF00735
Domain	G_SEPTIN_dom	SEPTIN8 SEPTIN3 SEPTIN14	8.37e-06	13	59	3	IPR030379
Domain	G_SEPTIN	SEPTIN8 SEPTIN3 SEPTIN14	8.37e-06	13	59	3	PS51719
Domain	Septin	SEPTIN8 SEPTIN3 SEPTIN14	1.06e-05	14	59	3	IPR016491
Domain	Myosin_tail_1	MYH1 CGN MYO18A	2.36e-05	18	59	3	PF01576
Domain	Myosin_tail	MYH1 CGN MYO18A	2.36e-05	18	59	3	IPR002928
Domain	ALDOKETO_REDUCTASE_1	AKR1B10 AKR1B1	4.34e-04	10	59	2	PS00798
Domain	Aldo/ket_reductase_CS	AKR1B10 AKR1B1	4.34e-04	10	59	2	IPR018170
Domain	Aldo/keto_reductase	AKR1B10 AKR1B1	4.34e-04	10	59	2	IPR020471
Domain	STI1	ST13P5 ST13	4.34e-04	10	59	2	SM00727
Domain	STI1_HS-bd	ST13P5 ST13	4.34e-04	10	59	2	IPR006636
Domain	ALDOKETO_REDUCTASE_2	AKR1B10 AKR1B1	4.34e-04	10	59	2	PS00062
Domain	ALDOKETO_REDUCTASE_3	AKR1B10 AKR1B1	4.34e-04	10	59	2	PS00063
Domain	-	AKR1B10 AKR1B1	1.14e-03	16	59	2	3.20.20.100
Domain	NADP_OxRdtase_dom	AKR1B10 AKR1B1	1.29e-03	17	59	2	IPR023210
Domain	Aldo_ket_red	AKR1B10 AKR1B1	1.29e-03	17	59	2	PF00248
Domain	Aldo/ket_red/Kv-b	AKR1B10 AKR1B1	1.29e-03	17	59	2	IPR001395
Domain	IQ	MYH1 MYO18A IQCG	1.47e-03	71	59	3	PF00612
Domain	Myosin-like_IQ_dom	MYH1 MYO18A	1.62e-03	19	59	2	IPR027401
Domain	-	MYH1 MYO18A	1.62e-03	19	59	2	4.10.270.10
Domain	IQ	MYH1 MYO18A IQCG	2.14e-03	81	59	3	SM00015
Domain	Actinin_actin-bd_CS	SYNE2 DMD	2.38e-03	23	59	2	IPR001589
Domain	Spectrin	SYNE2 DMD	2.38e-03	23	59	2	PF00435
Domain	ACTININ_2	SYNE2 DMD	2.38e-03	23	59	2	PS00020
Domain	ACTININ_1	SYNE2 DMD	2.38e-03	23	59	2	PS00019
Domain	TPR_1	CTR9 ST13P5 ST13	2.89e-03	90	59	3	PF00515
Domain	TPR_1	CTR9 ST13P5 ST13	2.89e-03	90	59	3	IPR001440
Domain	IQ_motif_EF-hand-BS	MYH1 MYO18A IQCG	2.89e-03	90	59	3	IPR000048
Domain	IQ	MYH1 MYO18A IQCG	3.18e-03	93	59	3	PS50096
Domain	Spectrin_repeat	SYNE2 DMD	3.77e-03	29	59	2	IPR002017
Domain	Spectrin/alpha-actinin	SYNE2 DMD	4.58e-03	32	59	2	IPR018159
Domain	SPEC	SYNE2 DMD	4.58e-03	32	59	2	SM00150
Domain	P-loop_NTPase	SEPTIN8 MYH1 SEPTIN3 SEPTIN14 MYO18A CHD2 DYNC1H1 RAD50	4.98e-03	848	59	8	IPR027417
Domain	TPR-like_helical_dom	KIFBP CTR9 ST13P5 ST13	6.28e-03	233	59	4	IPR011990
Domain	Myosin_head_motor_dom	MYH1 MYO18A	6.41e-03	38	59	2	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYO18A	6.41e-03	38	59	2	PS51456
Domain	Myosin_head	MYH1 MYO18A	6.41e-03	38	59	2	PF00063
Domain	MYSc	MYH1 MYO18A	6.41e-03	38	59	2	SM00242
Pathway	REACTOME_STRIATED_MUSCLE_CONTRACTION	TMOD1 DMD TNNT1	1.62e-04	35	43	3	MM15005
Pathway	REACTOME_STRIATED_MUSCLE_CONTRACTION	TMOD1 DMD TNNT1	1.76e-04	36	43	3	M18647
Pathway	WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY	TMOD1 DMD TNNT1	2.07e-04	38	43	3	M39549
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH1 USP8 UBXN4 CENPF CTR9 PPP1R9A SYNE2 ITSN2 ZBTB21 SYCP1 XRN1 MYO18A MAP7D2 CHD2 DMD SIPA1L2 TNNT1 NIPBL	6.93e-11	1442	64	18	35575683
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SEPTIN8 PPP1R9A AKR1B10 ITSN2 XRN1 MYO18A TMOD1 MAP7D2 EFHD2 RAI14 DMD SIPA1L2 AKR1B1 ST13P5 ST13 DYNC1H1 SNX2	5.57e-10	1431	64	17	37142655
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SEPTIN8 ITSN2 CGN XRN1 CCT6B MAP7D2 EFHD2 SIPA1L2 DYNC1H1 SNX2 RAD50	4.12e-07	853	64	11	28718761
Pubmed	Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain.	RTF1 SEPTIN8 UBXN4 MYO18A RB1CC1	4.68e-07	83	64	5	9039502
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CCDC13 KIFBP SEPTIN3 CENPF PPP1R9A SYNE2 ZBTB21 EFHD2 NIPBL DYNC1H1 RAD50	1.35e-06	963	64	11	28671696
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	KIFBP UBXN4 PAXBP1 NDUFAF2 CTR9 SYNE2 MYO18A MAP7D2 RB1CC1 SIPA1L2 ST13 SNX2 EFR3A	2.60e-06	1487	64	13	33957083
Pubmed	Localization of septin proteins in the mouse cochlea.	SEPTIN8 SEPTIN3 SEPTIN14	3.27e-06	16	64	3	22575789
Pubmed	Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians.	AKR1B10 AKR1B1	3.33e-06	2	64	2	15745835
Pubmed	Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).	AKR1B10 AKR1B1	3.33e-06	2	64	2	24100137
Pubmed	Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.	AKR1B10 AKR1B1	3.33e-06	2	64	2	28929377
Pubmed	Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway.	AKR1B10 AKR1B1	3.33e-06	2	64	2	32628753
Pubmed	Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism.	AKR1B10 AKR1B1	3.33e-06	2	64	2	12732097
Pubmed	Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks.	AKR1B10 AKR1B1	3.33e-06	2	64	2	33945128
Pubmed	Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry.	AKR1B10 AKR1B1	3.33e-06	2	64	2	28003428
Pubmed	Decreased levels of AKR1B1 and AKR1B10 in cancerous endometrium compared to adjacent non-cancerous tissue.	AKR1B10 AKR1B1	3.33e-06	2	64	2	23146748
Pubmed	Identification and characterization of a novel human aldose reductase-like gene.	AKR1B10 AKR1B1	3.33e-06	2	64	2	9565553
Pubmed	Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds.	AKR1B10 AKR1B1	3.33e-06	2	64	2	21329684
Pubmed	St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis.	ST13P5 ST13	3.33e-06	2	64	2	35562743
Pubmed	Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism.	AKR1B10 AKR1B1	3.33e-06	2	64	2	29617059
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	RTF1 SEPTIN8 USP8 KIFBP KMT5B CGN ZBTB21 RAI14 RB1CC1 AKR1B1 DYNC1H1 RAD50	3.39e-06	1284	64	12	17353931
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	USP8 RASSF2 RABGAP1L SYNE2 CGN ZBTB21 XRN1 RAI14 SIPA1L2 SNX2	3.71e-06	861	64	10	36931259
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	PPP1R9A RB1CC1 DYNC1H1 GOLGA6L1 RAD50	4.00e-06	128	64	5	23858473
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEPTIN8 KIFBP UBXN4 CECR2 ZBTB21 RAI14 CEP126 EFR3A	5.70e-06	529	64	8	14621295
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	CENPF XRN1 EFHD2 RAI14 DYNC1H1 EFR3A	7.87e-06	256	64	6	33397691
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	USP8 CGN XRN1 EFHD2 RAI14 RB1CC1 SNX2 EFR3A	9.19e-06	565	64	8	25468996
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP8 RABGAP1L PPP1R9A ITSN2 ANKRD12 SIPA1L2 DYNC1H1	9.99e-06	407	64	7	12693553
Pubmed	Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.	AKR1B10 AKR1B1	9.99e-06	3	64	2	17381426
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	SEPTIN8 MYO18A TMOD1 MAP7D2 RAI14 MAP3K13 SIPA1L2	1.42e-05	430	64	7	32581705
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	UBXN4 PAXBP1 SEPTIN3 CTR9 PPP1R9A ITSN2 XRN1 EFHD2 RAI14 CHD2 NIPBL EFR3A	1.59e-05	1497	64	12	31527615
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CENPF PPP1R9A SYNE2 CGN ZBTB21 RB1CC1 NIPBL DYNC1H1 SNX2 RAD50	1.68e-05	1024	64	10	24711643
Pubmed	Myomerger induces fusion of non-fusogenic cells and is required for skeletal muscle development.	MYH1 DMD	2.00e-05	4	64	2	28569755
Pubmed	Regulation of Skeletal Muscle Stem Cell Quiescence by Suv4-20h1-Dependent Facultative Heterochromatin Formation.	KMT5B DMD	2.00e-05	4	64	2	26669898
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEPTIN8 CTR9 SYNE2 RB1CC1	2.07e-05	87	64	4	12465718
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CENPF SYNE2 CGN XRN1 CHD2 NIPBL DYNC1H1 RAD50	2.60e-05	653	64	8	22586326
Pubmed	Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.	UBXN4 SYNE2 XRN1 EFHD2 RAI14	2.78e-05	191	64	5	31177093
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	PAXBP1 CENPF SYNE2 DMD RAD50	3.22e-05	197	64	5	20811636
Pubmed	Comparisons of genomic structures and chromosomal locations of the mouse aldose reductase and aldose reductase-like genes.	AKR1B10 AKR1B1	3.32e-05	5	64	2	10092857
Pubmed	YY1 regulates skeletal muscle regeneration through controlling metabolic reprogramming of satellite cells.	DMD TNNT1	3.32e-05	5	64	2	30979776
Pubmed	Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.	CGN MYO18A TMOD1 EFHD2 RAI14 DYNC1H1	3.52e-05	334	64	6	30425250
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	MYH1 RABGAP1L SYCP1 CHD2 CEP126 LRRD1 SNX2 KCNH5	3.68e-05	686	64	8	29987050
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	RTF1 YJU2 PAXBP1 CENPF CCT6B RAI14 DYNC1H1	4.02e-05	506	64	7	30890647
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	KIFBP PPP1R9A ITSN2 ZBTB21	4.02e-05	103	64	4	10574462
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SEPTIN8 UBXN4 SEPTIN3 RABGAP1L XRN1 MYO18A MAP7D2 SIPA1L2 ST13P5 ST13	4.15e-05	1139	64	10	36417873
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	RTF1 MYH1 RASSF2 CTR9 CHD2 MAP3K13 ANKRD36C RB1CC1 RAD50	4.19e-05	910	64	9	36736316
Pubmed	New and novel intrinsic host repressive factors against HIV-1: PAF1 complex, HERC5 and others.	RTF1 CTR9	4.98e-05	6	64	2	22405323
Pubmed	Direct interactions between the Paf1 complex and a cleavage and polyadenylation factor are revealed by dissociation of Paf1 from RNA polymerase II.	RTF1 CTR9	4.98e-05	6	64	2	18469135
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	PPP1R9A CGN RB1CC1 NIPBL DYNC1H1 SNX2	5.33e-05	360	64	6	33111431
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CGN XRN1 EFHD2 RAI14 DYNC1H1 SNX2 RAD50	6.71e-05	549	64	7	38280479
Pubmed	Sequence requirements of the FFAT-like motif for specific binding to VAP-A are revealed by NMR.	RB1CC1 SNX2	6.96e-05	7	64	2	34312846
Pubmed	The parafibromin tumor suppressor protein is part of a human Paf1 complex.	RTF1 CTR9	6.96e-05	7	64	2	15632063
Pubmed	Regulation of transcriptional elongation in pluripotency and cell differentiation by the PHD-finger protein Phf5a.	RTF1 CTR9	6.96e-05	7	64	2	27749823
Pubmed	Capturing novel mouse genes encoding chromosomal and other nuclear proteins.	RTF1 CECR2	6.96e-05	7	64	2	9701556
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	USP8 SYNE2 MYO18A TMOD1 EFHD2 DMD DYNC1H1 RAD50	7.13e-05	754	64	8	35906200
Pubmed	Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region.	SEPTIN8 RAD50	9.27e-05	8	64	2	9149945
Pubmed	Long noncoding RNA lncMREF promotes myogenic differentiation and muscle regeneration by interacting with the Smarca5/p300 complex.	MYH1 DMD	9.27e-05	8	64	2	36200826
Pubmed	Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin.	AKR1B10 AKR1B1	9.27e-05	8	64	2	20837989
Pubmed	Septin 14 is involved in cortical neuronal migration via interaction with Septin 4.	SEPTIN3 SEPTIN14	9.27e-05	8	64	2	20181826
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	RTF1 YJU2 CTR9 ZBTB21 EFHD2 CHD2 AKR1B1 NIPBL RAD50	9.60e-05	1014	64	9	32416067
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	USP8 CGN ZBTB21 RAI14 DYNC1H1	1.09e-04	255	64	5	15324660
Pubmed	Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle.	MYH1 DMD TNNT1	1.10e-04	50	64	3	27597886
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CCDC13 USP8 SEPTIN3 CTR9 CHMP3 RAI14 RILPL1 NIPBL ST13 DYNC1H1	1.13e-04	1285	64	10	35914814
Pubmed	The human PAF1 complex acts in chromatin transcription elongation both independently and cooperatively with SII/TFIIS.	RTF1 CTR9	1.19e-04	9	64	2	20178742
Pubmed	Association analysis of susceptibility candidate region on chromosome 5q31 for tuberculosis.	SEPTIN8 RAD50	1.19e-04	9	64	2	20485362
Pubmed	The human PAF complex coordinates transcription with events downstream of RNA synthesis.	RTF1 CTR9	1.19e-04	9	64	2	16024656
Pubmed	Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission.	SEPTIN8 SEPTIN3	1.19e-04	9	64	2	18809578
Pubmed	The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.	RTF1 CTR9	1.19e-04	9	64	2	15923622
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	CENPF ZBTB21 XRN1 RAI14 RB1CC1 RAD50	1.21e-04	418	64	6	34709266
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	UBXN4 CTR9 PPP1R9A SYNE2 CGN RAI14 DMD RB1CC1 EFR3A	1.24e-04	1049	64	9	27880917
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	USP8 PPP1R9A ITSN2 RAI14 DMD SIPA1L2	1.26e-04	421	64	6	36976175
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	USP8 KIFBP CTR9 RABGAP1L CGN ZBTB21 RAI14 DYNC1H1 CCDC40 RAD50	1.41e-04	1321	64	10	27173435
Pubmed	SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver.	RTF1 CTR9	1.49e-04	10	64	2	21726809
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	ITSN2 MYO18A CHMP3 EFHD2 RAI14 DYNC1H1 RAD50	1.51e-04	626	64	7	33644029
Pubmed	Analysis of the DNA sequence and duplication history of human chromosome 15.	GOLGA6L6 GOLGA6L22 CHD2	1.54e-04	56	64	3	16572171
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	SEPTIN8 UBXN4 RABGAP1L ST13P5 NIPBL ST13 DYNC1H1 RAD50	1.59e-04	847	64	8	35235311
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	USP8 KIFBP RASSF2 PPP1R9A CGN SIPA1L2	1.72e-04	446	64	6	24255178
Pubmed	The MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradation.	USP8 CHMP3	1.81e-04	11	64	2	17711858
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	CGN RAI14 CEP126 SIPA1L2	1.86e-04	153	64	4	10718198
Pubmed	RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma.	MYO18A EFHD2 RAI14	2.08e-04	62	64	3	35568845
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	SEPTIN8 MYO18A EFHD2 RAI14 AKR1B1 ST13 DYNC1H1 SNX2 RAD50	2.45e-04	1149	64	9	35446349
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	RTF1 USP8 PAXBP1 CTR9 SYNE2 EFHD2 NIPBL DYNC1H1 SPINK5 RAD50	2.46e-04	1415	64	10	28515276
Pubmed	CTR9/PAF1c regulates molecular lineage identity, histone H3K36 trimethylation and genomic imprinting during preimplantation development.	RTF1 CTR9	2.57e-04	13	64	2	24036311
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	KIFBP PAXBP1 CENPF CTR9 AKR1B1 NIPBL ST13 DYNC1H1 SNX2 RAD50	2.61e-04	1425	64	10	30948266
Pubmed	Analysis of gene expression in the developing mouse retina.	CHMP3 RAI14	2.99e-04	14	64	2	12702772
Pubmed	Defective excitation-contraction coupling is partially responsible for impaired contractility in hindlimb muscles of Stac3 knockout mice.	MYH1 TNNT1	2.99e-04	14	64	2	27184118
Pubmed	Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness.	MYH1 DMD	2.99e-04	14	64	2	28153048
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	KIFBP CTR9 AKR1B10 MYO18A EFHD2 AKR1B1	3.28e-04	503	64	6	36217030
Pubmed	System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.	RTF1 CTR9	3.45e-04	15	64	2	21406692
Pubmed	Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype.	MYH1 TNNT1	3.45e-04	15	64	2	24852826
Pubmed	The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.	MYO18A TMOD1 EFHD2 RAI14 RAD50	3.50e-04	328	64	5	23398456
Pubmed	MusTRD can regulate postnatal fiber-specific expression.	MYH1 TNNT1	3.93e-04	16	64	2	16494860
Pubmed	Identification of 40 genes on a 1-Mb contig around the IL-4 cytokine family gene cluster on mouse chromosome 11.	SEPTIN8 RAD50	3.93e-04	16	64	2	10704283
Pubmed	SHP-1 dephosphorylates histone H2B to facilitate its ubiquitination during transcription.	RTF1 CTR9	3.93e-04	16	64	2	35938192
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	SYNE2 MYO18A CCT6B DMD	4.00e-04	187	64	4	26460568
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	CTR9 XRN1 CCT6B EFHD2 DMD SIPA1L2 SNX2 RAD50	4.06e-04	974	64	8	28675297
Pubmed	Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families.	UBXN4 RABGAP1L EFHD2 RAI14 SNX2	4.07e-04	339	64	5	37232246
Pubmed	Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.	USP8 CGN RAI14 DYNC1H1	4.24e-04	190	64	4	15161933
Pubmed	WNT/β-catenin signaling plays a crucial role in myoblast fusion through regulation of nephrin expression during development.	MYH1 DMD	5.00e-04	18	64	2	30389854
Pubmed	RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells.	RTF1 CTR9	5.00e-04	18	64	2	19410543
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	YJU2 UBXN4 NDUFAF2 SYNE2 ITSN2 MAP7D2 EFHD2 SNX2	5.06e-04	1007	64	8	34597346
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PAXBP1 CTR9 ZBTB21 MYO18A NIPBL SNX2 RAD50	5.44e-04	774	64	7	15302935
Interaction	OFD1 interactions	KIFBP RASSF2 XRN1 TMOD1 CEP126 RB1CC1 DYNC1H1 RAD50	1.21e-05	347	63	8	int:OFD1
Interaction	CALD1 interactions	PPP1R9A CGN MYO18A TMOD1 RAI14 ST13P5 ST13	1.85e-05	265	63	7	int:CALD1
Interaction	KCTD13 interactions	SEPTIN8 PPP1R9A ITSN2 XRN1 MYO18A TMOD1 MAP7D2 EFHD2 RAI14 DMD SIPA1L2 AKR1B1 ST13 DYNC1H1 SNX2	1.91e-05	1394	63	15	int:KCTD13
Interaction	SYNPO interactions	PPP1R9A CGN MYO18A TMOD1 RAI14 RB1CC1	2.99e-05	192	63	6	int:SYNPO
Interaction	DBN1 interactions	RABGAP1L PPP1R9A CGN MYO18A TMOD1 RAI14 RB1CC1 NIPBL	4.50e-05	417	63	8	int:DBN1
Interaction	SYCE1 interactions	CFAP100 CENPF RABGAP1L SYCP1 RAD50	4.82e-05	127	63	5	int:SYCE1
Interaction	PPP1CA interactions	USP8 KIFBP PPP1R9A MYO18A CEP126 RB1CC1 CCDC181 ST13 DYNC1H1 RAD50	5.53e-05	696	63	10	int:PPP1CA
Interaction	STARD13 interactions	SYNE2 CGN ZBTB21 DMD	6.08e-05	68	63	4	int:STARD13
Interaction	SEPTIN12 interactions	SEPTIN8 SEPTIN3 CCT6B	7.19e-05	26	63	3	int:SEPTIN12
Interaction	SEPTIN10 interactions	SEPTIN8 KIFBP SEPTIN3 CENPF SEPTIN14	8.75e-05	144	63	5	int:SEPTIN10
Interaction	PPP1CB interactions	PPP1R9A MYO18A TMOD1 RAI14 RB1CC1 ST13 DYNC1H1 RAD50	1.02e-04	469	63	8	int:PPP1CB
Interaction	MECOM interactions	MYH1 RABGAP1L PPP1R9A RB1CC1 DYNC1H1 GOLGA6L1 RAD50	1.24e-04	358	63	7	int:MECOM
Interaction	KDM1A interactions	CFAP100 KIFBP CENPF RASSF2 RABGAP1L ITSN2 ZBTB21 XRN1 RAI14 RB1CC1 RAD50	1.44e-04	941	63	11	int:KDM1A
Interaction	SEPTIN14 interactions	SEPTIN8 SEPTIN3 SEPTIN14	1.49e-04	33	63	3	int:SEPTIN14
Interaction	YWHAZ interactions	USP8 KMT5B RASSF2 SYNE2 CGN ZBTB21 MYO18A RAI14 CEP126 RB1CC1 SIPA1L2 AKR1B1 DYNC1H1	1.84e-04	1319	63	13	int:YWHAZ
Interaction	NEXN interactions	CECR2 PPP1R9A MYO18A TMOD1	1.89e-04	91	63	4	int:NEXN
Interaction	CDC42 interactions	SEPTIN8 KIFBP UBXN4 PPP1R9A SYNE2 CGN MYO18A RAI14 MAP3K13 RB1CC1 AKR1B1 ST13 EFR3A	1.90e-04	1323	63	13	int:CDC42
Interaction	ARMC10 interactions	PPP1R9A MYO18A RB1CC1	2.10e-04	37	63	3	int:ARMC10
Interaction	SEPTIN4 interactions	SEPTIN8 SEPTIN3 SEPTIN14	2.27e-04	38	63	3	int:SEPTIN4
Interaction	LEPR interactions	USP8 XRN1 SNX2	2.46e-04	39	63	3	int:LEPR
Interaction	RDX interactions	CENPF PPP1R9A RAI14 AKR1B1 ST13 SNX2	2.57e-04	284	63	6	int:RDX
Interaction	FGD6 interactions	CTR9 CGN ZBTB21	2.65e-04	40	63	3	int:FGD6
Interaction	YWHAB interactions	USP8 RASSF2 CTR9 CGN ZBTB21 RAI14 RB1CC1 SIPA1L2 ST13 DYNC1H1 RAD50	2.75e-04	1014	63	11	int:YWHAB
Interaction	ACTC1 interactions	RTF1 YJU2 PAXBP1 CENPF SYNE2 CCT6B RAI14 DMD DYNC1H1	2.90e-04	694	63	9	int:ACTC1
Interaction	MTMR10 interactions	PPP1R9A CGN RAI14	3.06e-04	42	63	3	int:MTMR10
Cytoband	1q24	RABGAP1L CCDC181	3.58e-04	20	64	2	1q24
GeneFamily	Septins	SEPTIN8 SEPTIN3 SEPTIN14	3.05e-06	13	41	3	732
GeneFamily	Tetratricopeptide repeat domain containing\|Paf1/RNA polymerase II complex	RTF1 CTR9	7.48e-05	6	41	2	1029
GeneFamily	Aldo-keto reductases	AKR1B10 AKR1B1	5.17e-04	15	41	2	399
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	KIFBP CTR9 ST13	2.24e-03	115	41	3	769
GeneFamily	PDZ domain containing	PPP1R9A MYO18A SIPA1L2	4.92e-03	152	41	3	1220
Coexpression	GABRIELY_MIR21_TARGETS	RTF1 UBXN4 SYNE2 ITSN2 RAI14 DMD NIPBL	5.40e-06	289	62	7	M2196
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	USP8 RABGAP1L SYNE2 ITSN2 RAI14 RB1CC1 NIPBL SNX2 RAD50	2.27e-05	656	62	9	M18979
Coexpression	WANG_LMO4_TARGETS_DN	USP8 NDUFAF2 CGN DMD RB1CC1 SIPA1L2 DYNC1H1	2.28e-05	361	62	7	M12674
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	SEPTIN3 CENPF CECR2 RABGAP1L SYNE2 CGN TMOD1 MAP7D2 CHD2 DMD SIPA1L2 TNNT1	2.72e-05	983	63	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_200	CENPF CECR2 SYCP1 MAP7D2 IQCG	5.79e-05	139	63	5	gudmap_dev gonad_e13.5_M_GermCell_Oct_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	SEPTIN8 CENPF CECR2 SYNE2 ITSN2 MYO18A CHD2 RB1CC1 SIPA1L2 NIPBL	9.26e-05	780	63	10	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	RTF1 UBXN4 CENPF SYNE2 ANKRD12 RB1CC1 NIPBL RAD50	3.84e-10	198	63	8	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	RTF1 UBXN4 SYNE2 RAI14 ANKRD12 RB1CC1 NIPBL RAD50	4.00e-10	199	63	8	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	RTF1 UBXN4 SYNE2 ITSN2 ANKRD12 RB1CC1 NIPBL RAD50	4.00e-10	199	63	8	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	RTF1 UBXN4 SYNE2 ITSN2 ANKRD12 RB1CC1 NIPBL RAD50	4.00e-10	199	63	8	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PAXBP1 SYNE2 ITSN2 XRN1 CHD2 ANKRD12 NIPBL DYNC1H1	4.16e-10	200	63	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	RTF1 SYNE2 RAI14 ANKRD12 RB1CC1 NIPBL RAD50	1.05e-09	138	63	7	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	SYNE2 CHD2 ANKRD12 ANKRD36C RB1CC1 NIPBL DYNC1H1	9.03e-09	188	63	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	UBXN4 SYNE2 ANKRD12 CEP126 RB1CC1 NIPBL RAD50	1.34e-08	199	63	7	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	RTF1 UBXN4 SYNE2 ANKRD12 RB1CC1 NIPBL RAD50	1.34e-08	199	63	7	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	RTF1 UBXN4 SYNE2 ANKRD12 RB1CC1 NIPBL RAD50	1.34e-08	199	63	7	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	KIFBP FAM13C MYO18A CHD2 ANKRD12 DYNC1H1	1.92e-07	177	63	6	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP8 CECR2 ITSN2 XRN1 SLAMF7 NIPBL	2.26e-07	182	63	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP8 CECR2 ITSN2 XRN1 SLAMF7 NIPBL	2.49e-07	185	63	6	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	UBXN4 SYNE2 ANKRD12 RB1CC1 NIPBL RAD50	3.82e-07	199	63	6	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	RTF1 UBXN4 SYNE2 ANKRD12 RB1CC1 RAD50	3.82e-07	199	63	6	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP100 GOLGA6L22 CEP126 CCDC40 IQCG	5.65e-06	180	63	5	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	21-Trachea-Epithelial-Multiciliated_precursor\|Trachea / Age, Tissue, Lineage and Cell class	ZBTB21 CEP126 CCDC181 CCDC40 IQCG	5.96e-06	182	63	5	6e35892fa959ee31591850ded8f1088195ddeb01
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	SYNE2 EFHD2 ARHGAP25 SLAMF7 SIPA1L2	6.12e-06	183	63	5	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTF1 UBXN4 SYNE2 ANKRD12 NIPBL	6.80e-06	187	63	5	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	tumor_Lung-Epithelial_cells-tS3\|Epithelial_cells / Location, Cell class and cell subclass	CFAP100 CEP126 CCDC181 CCDC40 IQCG	6.80e-06	187	63	5	3cea677279e71fdb9879530dea10a5e6393beacd
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTF1 UBXN4 SYNE2 CHD2 NIPBL	6.97e-06	188	63	5	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	PND28-Epithelial\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PPP1R9A CGN CCDC181 SPINK5 IQCG	7.34e-06	190	63	5	89e5ddd830f70429d5b2fbaf8d0790b033450aa7
ToppCell	Ciliated-cil-3\|World / Class top	CFAP100 CCDC13 CCDC181 CCDC40 IQCG	7.72e-06	192	63	5	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	ASK452-Epithelial-Ciliated\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	CFAP100 CCDC13 CEP126 CCDC181 IQCG	8.12e-06	194	63	5	5aeb44657ab6f61b1abf98af28d3397d8e44c1aa
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CFAP100 CEP126 CCDC181 CCDC40 IQCG	8.54e-06	196	63	5	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	(05)_Ciliated\|World / shred by cell type and Timepoint	CFAP100 CCDC13 CCDC181 CCDC40 IQCG	8.75e-06	197	63	5	fee3cd16af8eea697cd64e8f64af505aaa2ac4b0
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP100 SYNE2 CEP126 DMD CCDC40	8.75e-06	197	63	5	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	RTF1 CHD2 ANKRD12 ANKRD36C RAD50	8.75e-06	197	63	5	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SYNE2 XRN1 ARHGAP25 CHD2 ANKRD12	8.97e-06	198	63	5	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CFAP100 CENPF CEP126 CCDC181 IQCG	8.97e-06	198	63	5	1847ce8c344c8a3e50f3cbbf758a38aba69f85b0
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP100 CEP126 CCDC181 CCDC40 IQCG	9.41e-06	200	63	5	cc906ff02fd335ff633b3b97afceb670494f910a
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP100 CEP126 CCDC181 CCDC40 IQCG	9.41e-06	200	63	5	79e59ab31d3d3385b1b072dc75508af9546c2e1b
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CFAP100 CEP126 CCDC181 CCDC40 IQCG	9.41e-06	200	63	5	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP100 CEP126 CCDC181 CCDC40 IQCG	9.41e-06	200	63	5	873def69bf55ccbfc944bc10c5afc06be019c312
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	SYNE2 XRN1 ANKRD12 NIPBL DYNC1H1	9.41e-06	200	63	5	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYH1 KMT5B SYNE2 SLAMF7	2.38e-05	118	63	4	5f72022f4be3fb7ccec86dc05d37572833028886
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYH1 KMT5B SYNE2 SLAMF7	2.38e-05	118	63	4	053c0986051e36fdc4c48b8067c137b6299b2f1b
ToppCell	Control-Lymphoid_T/NK-NK_activated\|Control / Disease group, lineage and cell class	MYH1 KMT5B SYNE2 SLAMF7	2.46e-05	119	63	4	a258d91ac90d4174b6f203d7f96ba6e57c6003e7
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYH1 KMT5B SYNE2 SLAMF7	2.46e-05	119	63	4	28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYH1 KMT5B SYNE2 SLAMF7	2.46e-05	119	63	4	0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	SYNE2 CHD2 ANKRD12 ANKRD36C	6.23e-05	151	63	4	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	PND03-Immune-Immune_Myeloid-DC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEPTIN3 RASSF2 EFHD2 SLAMF7	7.98e-05	161	63	4	f50e91f8363f20bb7c565aaca4d4961d3fe4b5b5
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	SYNE2 CHD2 ANKRD12 ANKRD36C	8.18e-05	162	63	4	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	droplet-Fat-SCAT-30m-Lymphocytic-B_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 RABGAP1L CCT6B AKR1B1	8.98e-05	166	63	4	4b31d2755108b2815316411a38bfb11fd30ef98a
ToppCell	droplet-Fat-SCAT-30m-Lymphocytic-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 RABGAP1L CCT6B AKR1B1	8.98e-05	166	63	4	67370c49d7aedcb4eca802095f06b30f6bbf8919
ToppCell	droplet-Fat-SCAT-30m-Lymphocytic\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 RABGAP1L CCT6B AKR1B1	8.98e-05	166	63	4	7f4e5976ede6478636aa567d6fc2b56ff7295fb8
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	CEP126 CCDC181 CCDC40 IQCG	9.20e-05	167	63	4	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEPTIN3 CENPF SLAMF7 SIPA1L2	9.41e-05	168	63	4	9b8a74abb83c64f0b5829dcb4275f722c82b45dc
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic-cDC1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEPTIN3 CENPF SLAMF7 SIPA1L2	9.41e-05	168	63	4	4b152b8d0f4a66faf664dfacb7914b18d60ce64a
ToppCell	PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEPTIN3 CENPF SLAMF7 SIPA1L2	9.41e-05	168	63	4	c3169ad8f4130ef18777ed86770bb722ffb5db85
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CEP126 DMD CCDC181 IQCG	9.63e-05	169	63	4	8bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231\|Adult / Lineage, Cell type, age group and donor	CECR2 SYNE2 RAI14 MAP3K13	9.85e-05	170	63	4	269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEPTIN3 CENPF EFHD2 SLAMF7	9.85e-05	170	63	4	9e94fa0d05abed3438b28296a293767096d517d6
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	SYNE2 CHD2 ANKRD12 ANKRD36C	1.01e-04	171	63	4	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFAP100 CCDC181 CCDC40 IQCG	1.13e-04	176	63	4	ed788a5969edfd1199828ca5b0dd34e7f29c4d30
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAXBP1 KMT5B XRN1 DMD	1.13e-04	176	63	4	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RABGAP1L ARHGAP25 SLAMF7 SNX2	1.15e-04	177	63	4	c506b8fd9a550e6cf93b64a1f7eed2543224a140
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RABGAP1L ARHGAP25 SLAMF7 SNX2	1.15e-04	177	63	4	840eaac045ada42cae0ab81177d1d0ae55a65633
ToppCell	PBMC-Severe-cDC_11\|Severe / Compartment, Disease Groups and Clusters	SEPTIN3 CECR2 DMD SLAMF7	1.18e-04	178	63	4	0667abc05eb2254710b9c648c65b7cfdfe7831b7
ToppCell	Ciliated_cells-A-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CFAP100 CEP126 CCDC181 CCDC40	1.20e-04	179	63	4	0e6c22de2e3fb0ff23b3301863cf4011c5c59dff
ToppCell	facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CFAP100 CCDC181 CCDC40 IQCG	1.20e-04	179	63	4	d4efbc34f52136039b96451fd0b0a0ad164197c6
ToppCell	facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CFAP100 CCDC181 CCDC40 IQCG	1.20e-04	179	63	4	8a66d197a2f55d763ff7ef0bec89ee96f59c3937
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CENPF EFHD2 ARHGAP25 KCNH5	1.20e-04	179	63	4	d3d3a9afaac28fa4f2c448c73d79bcbbbea088d7
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RABGAP1L ITSN2 SLAMF7 SNX2	1.23e-04	180	63	4	b83d067dee641941c596e4a25d81327931b6ad61
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 CCT6B TNNT1	1.23e-04	68	63	3	cfd75c373e10b3761666ccd445ba74755efeb95f
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 CCT6B TNNT1	1.23e-04	68	63	3	c25fb921dc83eecdc337353894829ae6b5192353
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 CCT6B TNNT1	1.23e-04	68	63	3	712f5f4d3a1e0c0db1a340332876206b93bdac31
ToppCell	P03-Epithelial-airway_epithelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CFAP100 CCDC13 CCDC181 CCDC40	1.25e-04	181	63	4	1ea21d860d4d7abab3e21e130a16d044006656ee
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFAP100 CCDC13 CEP126 CCDC40	1.25e-04	181	63	4	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	SYNE2 CHD2 ANKRD12 ANKRD36C	1.25e-04	181	63	4	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	Ciliated_cells-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CFAP100 CEP126 CCDC181 IQCG	1.28e-04	182	63	4	e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SYNE2 EFHD2 ARHGAP25 SLAMF7	1.31e-04	183	63	4	983ca1342ddd365e1f1df32a456394b002b10e41
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CECR2 PPP1R9A RAI14 MAP3K13	1.31e-04	183	63	4	6847c1252d6bb105524f812658112517fd351eab
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	RABGAP1L SYNE2 XRN1 CHD2	1.31e-04	183	63	4	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	droplet-Lung-LUNG-30m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFAP100 MAP3K13 CCDC40 IQCG	1.31e-04	183	63	4	3991830726d05cf19606d540de04093985b7bdeb
ToppCell	droplet-Lung-LUNG-30m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFAP100 MAP3K13 CCDC40 IQCG	1.31e-04	183	63	4	cc844f54c7564bf432b179ca63bc7c4b9b8cfdd9
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP8 ITSN2 XRN1 NIPBL	1.34e-04	184	63	4	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFAP100 CCDC181 CCDC40 IQCG	1.34e-04	184	63	4	797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFAP100 CCDC181 CCDC40 IQCG	1.34e-04	184	63	4	77d5b60a20b277f589b18f7a131142a7ef2dac17
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	CECR2 PPP1R9A RAI14 MAP3K13	1.36e-04	185	63	4	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	SEPTIN3 KMT5B SYNE2 ANKRD36C	1.36e-04	185	63	4	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	15-Trachea-Epithelial-Multiciliated_precursor\|Trachea / Age, Tissue, Lineage and Cell class	CENPF ZBTB21 CCDC181 IQCG	1.36e-04	185	63	4	9a8b8360d99375b726ca8e3c9a3f9b08919892d7
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RABGAP1L XRN1 ANKRD12 SLAMF7	1.36e-04	185	63	4	3b77bc49cd3740acc025e162a36282ac09e12198
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	CFAP100 CCDC13 CEP126 CCDC40	1.36e-04	185	63	4	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	P28-Epithelial-alveolar_epithelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RABGAP1L PPP1R9A CGN TMOD1	1.36e-04	185	63	4	5bb513e569f3a197d55ae2ca683e202daebabeac
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	FAM13C RABGAP1L DMD TNNT1	1.36e-04	185	63	4	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP100 CEP126 CCDC181 CCDC40	1.39e-04	186	63	4	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	Ciliated-cil-1\|World / Class top	CFAP100 CCDC181 CCDC40 IQCG	1.39e-04	186	63	4	283de646a0e8a322c42a714ae19db9918011146e
ToppCell	facs-Lung-18m-Epithelial-alveolar_epithelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PPP1R9A CGN TMOD1 SPINK5	1.39e-04	186	63	4	c7214e762b3b48197fdd0b36a50a4de2550a888f
ToppCell	PND14-Epithelial-Epithelial_Airway\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFAP100 CCDC181 CCDC40 IQCG	1.42e-04	187	63	4	1399c703505211c510b3f14c7a2aa9930566c473
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFAP100 CCDC13 CCDC40 IQCG	1.42e-04	187	63	4	04dba2ed09ee4180830bdf0191921696697ea234
ToppCell	Ciliated_cells-B-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CFAP100 CEP126 CCDC181 CCDC40	1.42e-04	187	63	4	2b4262c2e7c7830a976be168cee6eeb738d4feda
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	USP8 PPP1R9A RAI14 SPINK5	1.42e-04	187	63	4	6ab51e17a7782c2ae6394cad813dc3a2cde70c89
ToppCell	facs-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PPP1R9A CGN TMOD1 SPINK5	1.42e-04	187	63	4	a5318c888b334e8695f38971a7d100b93cdaf04b
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PAXBP1 CECR2 SYNE2 CGN	1.42e-04	187	63	4	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFAP100 CCDC13 CCDC40 IQCG	1.42e-04	187	63	4	805dafe22f835ece4dd091d8030d0a63b52a48dd
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	USP8 PPP1R9A RAI14 SPINK5	1.42e-04	187	63	4	e176b5b051690f840f3b12c8f7c4cc10cbe2bbae
ToppCell	facs-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PPP1R9A CGN TMOD1 SPINK5	1.42e-04	187	63	4	64ba0df991eab8b2632751805d758c5f2711f4d7
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	RABGAP1L RILPL1 DMD TNNT1	1.45e-04	188	63	4	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE2 EFHD2 ANKRD36C SLAMF7	1.45e-04	188	63	4	f8e6247bedc0ba494c5bb551539cb8ba5a97f557
Drug	oracin	AKR1B10 TNNT1 AKR1B1	6.85e-06	14	62	3	CID000160047
Drug	Pentanones	AKR1B10 AKR1B1	7.30e-06	2	62	2	ctd:D010422
Drug	4-hydroxyretinal	AKR1B10 AKR1B1	7.30e-06	2	62	2	ctd:C057180
Drug	4-oxoretinaldehyde	AKR1B10 AKR1B1	7.30e-06	2	62	2	ctd:C099660
Drug	propioin	AKR1B10 AKR1B1	7.30e-06	2	62	2	ctd:C523189
Drug	dehydroretinal	AKR1B10 AKR1B1	7.30e-06	2	62	2	ctd:C017184
Drug	2,4-hexadienal	AKR1B10 AKR1B1	2.18e-05	3	62	2	ctd:C079389
Drug	Acetoin	AKR1B10 AKR1B1	2.18e-05	3	62	2	ctd:D000093
Drug	2,3-butylene glycol	AKR1B10 AKR1B1	2.18e-05	3	62	2	ctd:C026978
Drug	negamycin	DMD SLAMF7	2.18e-05	3	62	2	CID000036458
Drug	5-Isothiocyanatoalrestatin	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID000124861
Drug	5-azidoalrestatin	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID000128442
Drug	5-(3-Thienyl)tetrazol-1-yl)acetic acid	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID003035658
Drug	FR-62765	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID000128354
Drug	M7HEQ	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID006452329
Drug	2,5-DHBQOP	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID000069213
Drug	NAP-HEX-Q	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID005487149
Drug	WF-2421	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID000195567
Drug	danshenol B	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID003083515
Drug	4-chloro-3-hydroxybutanoate	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID010129995
Drug	iodomethanesulfonamide	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID000519939
Drug	salviaflaside	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID006438919
Drug	matteuorienate A	AKR1B10 AKR1B1	4.36e-05	4	62	2	CID000190958
Drug	2-chloropropionate	ZBTB21 RB1CC1 DYNC1H1	5.37e-05	27	62	3	CID000011734
Drug	M79175	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID000115090
Drug	xanthone-2	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID005384285
Drug	AC1NE042	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID004634410
Drug	AC1L4VGL	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID000213726
Drug	4-chloro-3-nitrobenzaldehyde	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID000085505
Drug	2,3-hexanedione	AKR1B10 AKR1B1	7.26e-05	5	62	2	ctd:C043231
Drug	ICI 105552	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID000133677
Drug	2-(2,3,6-Trihydroxy-4-carboxyphenyl)ellagic acid	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID006918808
Drug	ICI 222155	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID000195716
Drug	DN-108	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID000183791
Drug	AD-5467	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID000197383
Drug	BAL-ARI8	AKR1B10 AKR1B1	7.26e-05	5	62	2	CID000130098
Drug	phenanthrene trans-1,2-dihydrodiol	AKR1B10 AKR1B1	1.09e-04	6	62	2	CID000115062
Drug	ICI 215918	AKR1B10 AKR1B1	1.09e-04	6	62	2	CID000129688
Drug	AC1L28UN	AKR1B10 AKR1B1	1.09e-04	6	62	2	CID000068017
Drug	M16287	AKR1B10 AKR1B1	1.09e-04	6	62	2	CID000188399
Drug	p225	AKR1B10 AKR1B1	1.09e-04	6	62	2	CID000014589
Drug	ADN-138	AKR1B10 AKR1B1	1.09e-04	6	62	2	CID000127323
Drug	BAPSG	AKR1B10 AKR1B1	1.09e-04	6	62	2	CID000130998
Drug	1,2,4-triazol-3-one	AKR1B10 AKR1B1	1.09e-04	6	62	2	CID011073339
Drug	capillarisin	AKR1B10 AKR1B1	1.09e-04	6	62	2	CID005281342
Drug	3,5-dichlorosalicylic acid	AKR1B10 AKR1B1	1.09e-04	6	62	2	CID000009445
Drug	myrciacitrin I	AKR1B10 AKR1B1	1.52e-04	7	62	2	CID000183137
Drug	friedelane	AKR1B10 AKR1B1	1.52e-04	7	62	2	CID000634354
Drug	4-chlorobenzaldehyde	SLAMF7 AKR1B1	1.52e-04	7	62	2	CID000007726
Drug	3-formylbenzoic acid	AKR1B10 AKR1B1	1.52e-04	7	62	2	CID000012077
Drug	tetramethylene glutaric acid	AKR1B10 AKR1B1	1.52e-04	7	62	2	CID000085558
Drug	guaijaverin	AKR1B10 AKR1B1	1.52e-04	7	62	2	CID005317847
Drug	desmanthin-1	AKR1B10 AKR1B1	1.52e-04	7	62	2	CID005316590
Drug	Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A	RTF1 SEPTIN8 CENPF RB1CC1 NIPBL	1.91e-04	195	62	5	1956_DN
Drug	Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; PC3; HT_HG-U133A	RTF1 PPP1R9A CCT6B ANKRD12 NIPBL	1.91e-04	195	62	5	7393_DN
Drug	erythritol 4-phosphate	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000192838
Drug	4-hydroxynonanoate	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000134653
Drug	Risarestat	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000133264
Drug	6-pyridoxyllysine	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000160700
Drug	propranolol glycol	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000037369
Drug	1,2-diaminoguanidine	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000170039
Drug	20-CHO-LTB4	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID006449839
Drug	CP-166,572	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000132302
Drug	alcophosphamide	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000098612
Drug	eutypine	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000129326
Drug	SG-210	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000132542
Drug	NSC633676	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000133894
Drug	3 Na	AKR1B10 AKR1B1	2.02e-04	8	62	2	CID000157838
Drug	Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A	RTF1 PPP1R9A ANKRD12 RB1CC1 NIPBL	2.10e-04	199	62	5	1933_DN
Drug	AL3152	AKR1B10 AKR1B1	2.59e-04	9	62	2	CID000159501
Drug	AC1Q5HJP	AKR1B10 AKR1B1	2.59e-04	9	62	2	CID000000067
Drug	3-deoxyfructose	AKR1B10 AKR1B1	2.59e-04	9	62	2	CID003080627
Drug	potassium amyl xanthate	AKR1B10 AKR1B1	2.59e-04	9	62	2	CID000017635
Drug	metyrapol	AKR1B10 AKR1B1	2.59e-04	9	62	2	CID000161210
Drug	B0683	MYH1 MYO18A DMD TNNT1	2.94e-04	117	62	4	CID006398969
Drug	oxovanadium	MYH1 DMD TNNT1 DYNC1H1	3.23e-04	120	62	4	CID000024411
Drug	mycaminose	AKR1B10 AKR1B1	3.24e-04	10	62	2	CID000160504
Drug	2,3-hexanedione	AKR1B10 AKR1B1	3.24e-04	10	62	2	CID000019707
Drug	Hexanones	AKR1B10 AKR1B1	3.24e-04	10	62	2	ctd:D006588
Drug	3-fluoro-3-deoxy-D-glucose	AKR1B10 AKR1B1	3.24e-04	10	62	2	CID000122305
Drug	lys-val	AKR1B10 AKR1B1	3.24e-04	10	62	2	CID000140709
Drug	Glyceraldehyde	AKR1B10 AKR1B1	3.24e-04	10	62	2	ctd:D005985
Drug	Dihydroxydihydrobenzopyrenes	AKR1B10 AKR1B1	3.95e-04	11	62	2	ctd:D004101
Drug	chlordecone alcohol	AKR1B10 AKR1B1	3.95e-04	11	62	2	CID000013946
Drug	NSC 60462	AKR1B10 AKR1B1	3.95e-04	11	62	2	CID000097943
Drug	sorbitol-3-phosphate	AKR1B10 AKR1B1	4.73e-04	12	62	2	CID000129544
Drug	AL-4114	AKR1B10 AKR1B1	4.73e-04	12	62	2	CID000164424
Drug	AC1MRDQ4	AKR1B10 AKR1B1	4.73e-04	12	62	2	CID003491289
Drug	purealin	MYH1 MYO18A DYNC1H1	5.33e-04	58	62	3	CID006419303
Drug	bendazac	ZBTB21 AKR1B1	5.58e-04	13	62	2	CID000002313
Drug	befunolol	AKR1B10 AKR1B1	5.58e-04	13	62	2	CID000002309
Drug	PNAP	AKR1B10 AKR1B1	5.58e-04	13	62	2	CID000007487
Drug	4-formyl-benzoate	AKR1B10 AKR1B1	5.58e-04	13	62	2	CID000012088
Drug	2-hexenal	AKR1B10 AKR1B1	5.58e-04	13	62	2	ctd:C051750
Drug	acetohexamide	AKR1B10 AKR1B1	5.58e-04	13	62	2	CID000001989
Drug	NSC339663	MYH1 SYNE2 ITSN2 SYCP1 MYO18A	5.96e-04	250	62	5	CID000003892
Disease	aldose reductase measurement	AKR1B10 AKR1B1	2.35e-05	4	59	2	EFO_0801364
Disease	drug use measurement, quality of life during menstruation measurement	SYCP1 KCNH5	8.20e-05	7	59	2	EFO_0007010, EFO_0009366
Disease	white matter growth measurement	AKR1B10 AKR1B1	1.40e-04	9	59	2	EFO_0009335
Disease	Malignant neoplasm of breast	MYH1 CENPF SYNE2 ITSN2 MAP7D2 MAP3K13 DMD RB1CC1 NIPBL	2.65e-04	1074	59	9	C0006142
Disease	Microcephaly	KIFBP CENPF DYNC1H1	3.32e-04	67	59	3	C0025958
Disease	Malformations of Cortical Development	KIFBP DYNC1H1	3.52e-04	14	59	2	C1955869
Disease	Cortical Dysplasia	KIFBP DYNC1H1	3.52e-04	14	59	2	C0431380
Disease	level of Sphingomyelin (d32:1) in blood serum	SYNE2 KCNH5	5.24e-04	17	59	2	OBA_2045173
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 CENPF DMD	5.59e-04	80	59	3	DOID:12930 (implicated_via_orthology)
Disease	inosine measurement	DMD KCNH5	6.58e-04	19	59	2	EFO_0010503
Disease	intrinsic cardiomyopathy (implicated_via_orthology)	CCT6B TNNT1	8.05e-04	21	59	2	DOID:0060036 (implicated_via_orthology)
Disease	Severe Congenital Microcephaly	KIFBP DYNC1H1	1.76e-03	31	59	2	C3853041
Disease	clopidogrel metabolite measurement	MYO18A CCT6B	1.99e-03	33	59	2	EFO_0007966
Disease	Microlissencephaly	KIFBP DYNC1H1	1.99e-03	33	59	2	C1956147

Protein segments in the cluster

Peptide	Gene	Start	Entry
DIQREEEKVKRSVKD	CHMP3	36	Q9Y3E7
EKIQEKAVKREDLFI	AKR1B10	61	O60218
EKVNAIEREKAEKFR	DMD	761	P11532
QRITDERKREEIKIK	DMD	1836	P11532
SFREEKIKDLKEERE	ANKRD12	761	Q6UB98
IEKQKRKEEEEERQI	CECR2	326	Q9BXF3
EEQEKEKRRLVIEKF	EFR3A	741	Q14156
EKLREQVVKREELFI	AKR1B1	61	P15121
QVIIEDRIEKERSKK	IQCG	371	Q9H095
KHEEREIKERIERVK	ST13P5	241	Q8NFI4
EIKERIERVKKAQEE	ST13P5	246	Q8NFI4
EIKERIERVKKAREE	ST13	246	P50502
EKVRELEEKLVEREK	RAI14	551	Q9P0K7
FIQKLQEEEDREVKK	RASSF2	286	P50749
KRNEELKEVEEERKQ	RAD50	1026	Q92878
EKIQEEERKAEEKQR	ITSN2	726	Q9NZM3
IIKKQDEQIERFEKI	ANKRD36C	1751	Q5JPF3
LKEFKLEREVVEKEL	RB1CC1	1246	Q8TDY2
DERDEKILEKIFKIV	LRRD1	756	A4D1F6
AVEEKRKQKLREEEE	MAP7D2	111	Q96T17
VFQKENEERKRKEEE	SPINK5	671	Q9NQ38
KGRQEELKEVIERFK	KMT5B	131	Q4FZB7
FRKISDVKKEEEERL	KCNH5	676	Q8NCM2
KKRLQQEFEDKLEVE	MYO18A	1386	Q92614
IERERFSKEVQDKDK	NIPBL	486	Q6KC79
KIREQEEKRQEEEKI	GOLGA6L1	391	Q8N7Z2
EKIREQEEKIREQKE	GOLGA6L1	571	Q8N7Z2
EKIREQEEKIREQEK	GOLGA6L6	411	A8MZA4
IREQEKKIREQEEKI	GOLGA6L6	651	A8MZA4
KKIREQEEKIREQEE	GOLGA6L6	656	A8MZA4
EKIREQEEKIREQKE	GOLGA6L22	616	H0YM25
EKIREQEKKIREQEE	GOLGA6L22	686	H0YM25
EKKIREQEEKIREQE	GOLGA6L22	741	H0YM25
IEELKRQLEEEIKAK	MYH1	1316	P12882
DDDEKRRIVFSVKEK	PAXBP1	266	Q9Y5B6
KQRLVETEEEKRKQE	RABGAP1L	66	B7ZAP0
KFRAEEVAIKKVREQ	MAP3K13	186	O43283
EEERRKIEEEKEKKR	CCDC181	356	Q5TID7
IEKLRVRIEADEKKQ	CENPF	2121	P49454
QRKKVEEEERQKELE	CHD2	1051	O14647
EEKRKEQEEKEHQIR	CEP126	86	Q9P2H0
ETERIRAEIEKKKQD	CCDC40	426	Q4G0X9
DVLQRELEELKKKFE	CCDC13	336	Q8IYE1
LLKEQEEKRLREKEE	CTR9	856	Q6PD62
QVKIEQAERAKEKER	CFAP100	526	Q494V2
ERIQKIKREKEERGE	DYNC1H1	2106	Q14204
RFEEEIKAEQEERKK	EFHD2	206	Q96C19
EEKLTEQERSKRFEK	KIFBP	191	Q96EK5
DIEEIVKEKERFRKA	RTF1	491	Q92541
IRKEVGRFEKERVKD	SNX2	471	O60749
KAERKFIEDRVQKII	CCT6B	261	Q92526
FIEDRVQKIIDLKDK	CCT6B	266	Q92526
FEQRKKEEEELVALK	TNNT1	86	P13805
QEEIRKLEEEKKQLE	SEPTIN14	386	Q6ZU15
KKRIAEIEIVKEEFN	SYNE2	1571	Q8WXH0
VSIRREKVEDAKEKE	SIPA1L2	511	Q9P2F8
LKRKIRKFEEKFEQE	FAM13C	296	Q8NE31
RKVEELQRKLDEEVK	CGN	366	Q9P2M7
EKFQRKLIDIVRERE	ZBTB21	616	Q9ULJ3
LKEVVDKQRDEIRAK	RILPL1	166	Q5EBL4
LEKQAKEFKDREDLV	TMOD1	71	P28289
EKSEFKQRVRKELEV	SEPTIN3	216	Q9UH03
QLEIEREEKEKLKRE	SYCP1	766	Q15431
EKRNKALEEEVKEFV	ARHGAP25	621	P42331
IVEKIEEEVEKCKQR	XRN1	1056	Q8IZH2
IREKRIVEAANKKEV	NDUFAF2	46	Q8N183
KRKVEEKRRELEEET	SEPTIN8	381	Q92599
KRERQEEYIEEKKRV	SLAMF7	251	Q9NQ25
EKLLEEEEKRVQKER	YJU2	111	Q9BW85
EEEQREIKKEIERRK	UBXN4	216	Q92575
AEVRKKLEEKDRQEE	USP8	116	P40818
FIKRQEAERKKIEDL	PPP1R9A	781	Q9ULJ8